Jean-Luc Gerling

The Biopharma industry is at a pivot point. Increasing cost pressure and growing regulations require new approach towards research and the production of drugs. Personalized medicine and other market trends demand smaller batches with variable production parameters. To answer the market demand, Merck is rethinking and redesigning every part of the ecosystem, integrating new technologies with industrial automation platforms to deliver game changing capabilities for drug manufacturers. This session will explore the concepts, design principles, challenges and achievements of the interdisciplinary team which is on a mission to revolutionize the way drugs are discovered and produced.